DeepSeek’s disruption shakes global tech stocks: A turning point in the AI industry?
The global technology sector has entered turbulent waters, with major stocks experiencing significant declines following the unexpected rise of DeepSeek, a Chinese artificial intelligence (AI) ... Read More
Vimgreen Pharmaceuticals progresses with Phase 2 trial of VG081821AC for Parkinson’s disease
Vimgreen Pharmaceuticals has marked a significant milestone with the completion of participant enrollment in its Phase 2 clinical trial for VG081821AC, a cutting-edge treatment for ... Read More